Specific sequelae symptoms of COVID-19 of Omicron variant in comparison with non-COVID-19 patients: a retrospective cohort study in Japan

被引:0
|
作者
Omori, Takahiro [1 ]
Hanafusa, Mariko [1 ,2 ]
Kondo, Nobuyuki [1 ,3 ]
Miyazaki, Yasunari [1 ,3 ]
Okada, Shusho [1 ,4 ]
Fujiwara, Takeo [1 ,5 ]
Kuramochi, Jin [1 ,3 ]
机构
[1] Kuramochi Clin Interpk, Dept Resp Med, Nakajima Cho 765-1, Utsunomiya, Tochigi 3210114, Japan
[2] Tokyo Med & Dent Univ, Dept Tokyo Metropolitan Hlth Policy Advisement, Tokyo, Japan
[3] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo 1138510, Japan
[4] Tokyo Med & Dent Univ, Dept Hlth Policy, Tokyo, Japan
[5] Tokyo Med & Dent Univ, Dept Publ Hlth, Tokyo, Japan
关键词
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); Omicron; long-term sequela of coronavirus disease 2019 (long COVID); sequelae;
D O I
10.21037/jtd-23-1822
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The specific long-term sequela of coronavirus disease 2019 (COVID-19), also known as long COVID of the Omicron variant remain unclear, due to a lack of cohort studies that include non-COVID patients with cold -like symptoms. The study was conducted to examine specific sequelae symptoms after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, which is considered the Omicron variant, compared with patients who were never -infected. Methods: In this retrospective cohort study, we sent questionnaires in November 2022, targeting those who visited our fever outpatient unit of a single institution from July to September 2022. SARS-CoV-2 infection status was determined by SARS-CoV-2 polymerase chain reaction (PCR) test results during the study period collected in electronic medical records. Clinical characteristics at 30 days or more since the date of SARS-CoV-2 PCR test were assessed by the questionnaires. Multiple logistic regression was performed to investigate the independent association between SARS-CoV-2 infection and possible sequelae symptoms. Results: In total, valid responses were received from 4,779 patients (mean age: 41.4 years, standard deviation: 19.8 years old). Among them, 3,326 (69.6%) and 1,453 (30.4%) were SARS-CoV-2 PCR test positive and never -infected, respectively. We found that patients with SARS-CoV-2 infection were more likely to have a loss of taste or smell [odds ratio (OR) 4.55, 95% confidence interval (CI): 1.93, 10.71], hair loss (OR 3.19, 95% CI: 1.67, 6.09), neurocognitive symptoms (OR 1.95, 95% CI: 1.43, 2.65), and respiratory symptoms (OR 1.23, 95% CI: 1.03, 1.47) than never -infected patients. SARS-CoV-2 infection was not associated with common cold symptoms, chronic physical distress, or diarrhea as sequelae symptoms. Further, SARS-CoV-2 vaccination showed protective effects on sequelae of loss of taste or smell and hair loss. Conclusions: Loss of taste or smell, hair loss, neurocognitive symptoms, and respiratory symptoms were found to be specific sequelae of the SARS-CoV-2 Omicron variant. It is important not to miss these symptoms that follow SARS-CoV-2 infection and to recognize and manage the long COVID.
引用
收藏
页码:3170 / +
页数:13
相关论文
共 50 条
  • [31] Comparison of Perioperative Characteristics and Clinical Outcomes of COVID-19 and non-COVID-19 Patients Undergoing Neurosurgery-A Retrospective Analysis
    Mishra, Rajeeb K.
    Sriganesh, Kamath
    Surve, Rohini M.
    Sangeetha, R. P.
    Chakrabarti, Dhritiman
    Shashidhar, Abhinith
    Anju, Janaki L.
    JOURNAL OF NEUROANAESTHESIOLOGY AND CRITICAL CARE, 2022, 09 (02) : 99 - 105
  • [32] Audiovestibular symptoms and sequelae in COVID-19 patients
    Gallus, Roberto
    Melis, Andrea
    Rizzo, Davide
    Piras, Antonio
    De Luca, Laura Maria
    Tramaloni, Pierangela
    Serra, Antonello
    Longoni, Eleonora
    Soro, Giovanni Maria
    Bussu, Francesco
    JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION, 2021, 31 (05): : 381 - 387
  • [33] Does COVID-19 affect thyroid more than non-COVID-19 infections? A retrospective study
    Ucal, Yasemin
    Serdar, Muhittin
    Karpuzoglu, Hande
    Yurttutan Uyar, Neval
    Kilercik, Meltem
    Serteser, Mustafa
    Ozpinar, Aysel
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2024, 49 (02): : 227 - 235
  • [34] Comparison of pneumonia severity scores for COVID-19 patients with the Omicron variant
    Miyashita, Naoyuki
    Nakamori, Yasushi
    Ogata, Makoto
    Fukuda, Naoki
    Yamura, Akihisa
    Ito, Tomoki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (05) : 463 - 466
  • [35] Comparison of sleep quality among COVID-19 patients and non-COVID-19 population in Pakistan: A cross sectional study during the COVID-19 pandemic
    Malik, Muna
    Atiq, Ayesha
    Tahir, Muhammad Junaid
    Akhtar, Fahd Kamal
    Malik, Muhammad Irfan
    Hassan, Wardah
    Khan, Fatima Muhammad Asad
    Akram, Iqra
    Manhas, Noraiz
    Ullah, Irfan
    Asghar, Muhammad Sohaib
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [36] Warning of the COVID-19 Novel Variant: Is the COVID-19 Omicron Variant a Real Danger for Cancer Patients or Not?
    Ghalibaf, Amir Ali Moodi
    Rad, Mina Akbari
    Karizmeh, Mehdi Ataee
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2022, 24 (06)
  • [37] Comparison of sleep quality among COVID-19 patients and non-COVID-19 population in Pakistan: A cross sectional study during the COVID-19 pandemic
    Malik, Muna
    Atiq, Ayesha
    Tahir, Muhammad Junaid
    Akhtar, Fahd Kamal
    Malik, Muhammad Irfan
    Hassan, Wardah
    Khan, Fatima Muhammad Asad
    Akram, Iqra
    Manhas, Noraiz
    Ullah, Irfan
    Asghar, Muhammad Sohaib
    ANNALS OF MEDICINE AND SURGERY, 2022, 78
  • [38] Comparison of clinical outcomes in hospitalized patients with COVID-19 or non-COVID-19 community-acquired pneumonia in a prospective observational cohort study
    Meyer, Hans-Jakob
    Moedl, Lukas
    Unruh, Olesya
    Xiang, Weiwei
    Berger, Sarah
    Mueller-Plathe, Moritz
    Rohde, Gernot
    Pletz, Mathias W.
    Rupp, Jan
    Suttorp, Norbert
    Witzenrath, Martin
    Zoller, Thomas
    Mittermaier, Mirja
    Steinbeis, Fridolin
    INFECTION, 2024, 52 (06) : 2359 - 2370
  • [39] CISATRACURIUM DOSING REQUIREMENTS IN COVID-19 COMPARED TO NON-COVID-19 PATIENTS
    Ingebrigtson, Megan
    Farina, Nicholas
    Miller, James
    Renius, Karl
    Kenes, Michael
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 128 - 128
  • [40] Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients
    Ingebrigtson, Megan
    Farina, Nicholas
    Miller, James
    Renius, Karl
    McSparron, Jakob I.
    Kenes, Michael
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (03) : 485 - 486